Carvedilol Tablets 10mg (Carvedilol “DSEP”® / カルベジロール錠10mg「DSEP」)

JPY ¥1,900

Japanese sustained-action antihypertensive/antianginal and chronic heart failure treatment agent (Carvedilol 10mg). For oral administration in essential hypertension, angina pectoris, chronic heart failure, and tachycardic atrial fibrillation. 100 tablets (10 tablets x 10). Mfd. by Daiichi Sankyo Espha Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,748
10 - 19 12% JPY ¥1,672
20 + 18% JPY ¥1,558
SKU: CAR-10-TAB Category:

Description

Product Overview / 商品概要

Carvedilol Tablets 10mg “DSEP” (カルベジロール錠10mg「DSEP」)
Generic: Carvedilol / カルベジロール
Therapeutic Category: Sustained-action Antihypertensive/Antianginal Agent / Chronic Heart Failure Treatment Agent / Tachycardic Atrial Fibrillation Treatment Agent / 持続性 高血圧・狭心症治療剤 / 慢性心不全治療剤 / 頻脈性心房細動治療剤
Manufactured by: Daiichi Sankyo Espha Co., Ltd. / 第一三共エスファ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Carvedilol (JP) 10mg per tablet / 1錠中 カルベジロール(日局)10mg
Additives: Lactose hydrate, Corn starch, Low-substituted hydroxypropylcellulose, Polyvinyl alcohol (partially saponified), Light anhydrous silicic acid, Magnesium stearate, Hypromellose, Titanium oxide, Talc, Propylene glycol, Dimethylpolysiloxane, Silicon dioxide, Yellow ferric oxide, Carnauba wax / 乳糖水和物、トウモロコシデンプン、低置換度ヒドロキシプロピルセルロース、ポリビニルアルコール(部分けん化物)、軽質無水ケイ酸、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、タルク、プロピレングリコール、ジメチルポリシロキサン、二酸化ケイ素、黄色三二酸化鉄、カルナウバロウ
Appearance: Yellow film-coated tablet (scored), diameter 8.1mm, thickness approx. 3.3mm, weight approx. 154mg, identification code: CVL/ep
外観: 黄色のフィルムコーティング錠(割線入)、直径8.1mm、厚さ約3.3mm、重さ約154mg、識別コード: CVL/ep

Indications / 効能効果

EN: Essential hypertension (mild to moderate), Renal parenchymal hypertension, Angina pectoris, Chronic heart failure due to ischemic heart disease or dilated cardiomyopathy in patients receiving basic treatment with ACE inhibitors, diuretics, digitalis preparations, etc., Tachycardic atrial fibrillation
JA: 本態性高血圧症(軽症~中等症)、腎実質性高血圧症、狭心症、次の状態でアンジオテンシン変換酵素阻害薬、利尿薬、ジギタリス製剤等の基礎治療を受けている患者:虚血性心疾患又は拡張型心筋症に基づく慢性心不全、頻脈性心房細動

Dosage and Administration / 用法用量

EN: Essential hypertension (mild to moderate) / Renal parenchymal hypertension: Usually 10–20mg once daily orally in adults; adjust according to age and symptoms. Angina pectoris: Usually 20mg once daily orally in adults; adjust according to age and symptoms. Chronic heart failure (ischemic heart disease or dilated cardiomyopathy): Start at 1.25mg twice daily orally after meals; increase stepwise at intervals of at least 1 week; maintenance dose 2.5–10mg twice daily after meals. Tachycardic atrial fibrillation: Start at 5mg once daily orally; increase stepwise to 10mg then 20mg once daily if insufficient effect; maximum dose 20mg once daily.
JA: 〈本態性高血圧症(軽症~中等症)、腎実質性高血圧症〉通常、成人1回10~20mgを1日1回経口投与。年齢、症状により適宜増減。〈狭心症〉通常、成人1回20mgを1日1回経口投与。年齢、症状により適宜増減。〈虚血性心疾患又は拡張型心筋症に基づく慢性心不全〉通常、成人1回1.25mg、1日2回食後経口投与から開始。1週間以上の間隔で段階的に増量し、維持量として1回2.5~10mgを1日2回食後経口投与。〈頻脈性心房細動〉通常、成人1回5mgを1日1回経口投与から開始し、効果不十分な場合には10mg、20mgへ段階的に増量。最大投与量は20mgを1日1回。

Contraindications / 禁忌

EN: Patients with bronchial asthma or risk of bronchospasm; patients with diabetic ketoacidosis or metabolic acidosis; patients with severe bradycardia (marked sinus bradycardia), AV block (grade II or III), or sinoatrial block; patients in cardiogenic shock; heart failure patients requiring intravenous inotropic or vasodilatory agents; patients with decompensated heart failure; patients with right heart failure due to pulmonary hypertension; patients with untreated pheochromocytoma or paraganglioma; patients with a history of hypersensitivity to any component of this product
JA: 気管支喘息・気管支痙攣のおそれのある患者、糖尿病性ケトアシドーシス・代謝性アシドーシスのある患者、高度の徐脈(著しい洞性徐脈)・房室ブロック(Ⅱ・Ⅲ度)・洞房ブロックのある患者、心原性ショックの患者、強心薬又は血管拡張薬を静脈内投与する必要のある心不全患者、非代償性の心不全患者、肺高血圧による右心不全のある患者、未治療の褐色細胞腫又はパラガングリオーマの患者、本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30300AMX00351
Sales Started: December 2021 / 2021年12月
Classification Code: 872149
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (10 tablets x 10) / 100錠(10錠×10)
Other Available Packages (by special order): Plastic bottle (bulk): 500 tablets; PTP: 100 tablets (10 tablets x 10), 420 tablets (14 tablets x 30), 500 tablets (10 tablets x 50)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Carvedilol Tablets 10mg (Carvedilol “DSEP”® / カルベジロール錠10mg「DSEP」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Carvedilol Tablets 10mg (Carvedilol "DSEP"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.